Gink­go Bioworks hand­ed a DARPA man­u­fac­tur­ing con­tract; Mer­ck hits a pri­ma­ry end­point for Keytru­da in first-line cer­vi­cal can­cer

The De­fense Ad­vanced Re­search Projects Agency (DARPA) is giv­ing Gink­go Bioworks a 4-year con­tract worth up to $18 mil­lion, to man­u­fac­ture com­plex ther­a­peu­tic pro­teins. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER